China Universal Asset Management »

Rani Therapeutics Hldgs shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 16k 1.35
2022-09-30 $2.0k 229 8.73

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Rani Therapeutics Hldgs

Samsara BioCapital
AWM Investment Company
Vanguard Group
Susquehanna International
Siren
Jane Street
Geode Capital Management
BlackRock
Nan Fung Group Holdings
683 Capital Management
Citadel Advisors
State Street Corporation
Squarepoint Ops
United Services Automobile Association
Goldman Sachs Group

View all funds holding Rani Therapeutics Hldgs